Recombinant human parathyroid hormone - Green Cross

Drug Profile

Recombinant human parathyroid hormone - Green Cross

Alternative Names: rhPTH - Green Cross

Latest Information Update: 06 Jul 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Green Cross
  • Class
  • Mechanism of Action Osteogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Osteoporosis

Most Recent Events

  • 06 Jul 2010 Discontinued - Phase-II for Osteoporosis in Germany (unspecified route)
  • 31 May 2006 Recombinant human parathyroid hormone has been licensed to BDD/CCDRD Group in regions outside Asia
  • 29 Jul 2005 Phase-II clinical trials in Osteoporosis in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top